A woman from Shropshire has become the first patient in the UK to receive teplizumab through routine NHS care, following the ...

The Obesity & Weight Management Alliance anticipate that they will receive sponsorship from pharmaceutical companies and MedTech organisations for the 2027 conferences. As soon as sponsorship is ...

Leading international experts will discuss the diagnosis, screening and treatment of cardiovascular autonomic neuropathy and diabetic gastroenteropathy during a free educational webinar this November.

New guidelines to improve the quality of care for people with diabetes living in care homes have been released. They provide a series of indicators that can help inspectors to assess whether a service ...

This guideline constructs a framework for the recognition and management of steroid induced hyperglycaemia and steroid induced diabetes, and is designed for use by general physicians. Necessarily, the ...

The main purpose of this guidance is first, to reduce the inequity of diabetes care for people with severe mental illness (typically those with schizophrenia and bipolar disorders) by clarifying that ...

Decreased vitamin B12 serum levels are now considered to be a common side effect in people on metformin treatment, new guidance from the Medicines and Healthcare products Regulatory Agency has ...

Ozempic ® (semaglutide), a new once-weekly GLP-1 analogue injection for the treatment of type 2 diabetes, is now available in the UK, Novo Nordisk UK has announced. It works by mimicking the function ...

A traumatic event during childhood can triple the risk of subsequently developing Type 1 diabetes, researchers have concluded. A new study from Sweden published in Diabetologia (the journal of the ...

A new recycling scheme has been introduced in the UK by Roche Diabetes Care in a bid to reduce waste. The company has announced plans to go green where possible as part of a wider global commitment ...